Orbimed Advisors Trims $125 After Breakout Year in Biotech
A major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
In stock indices, level denotes a specific point on the index scale, reflecting aggregated price movement and market breadth.
23,381 articlesA major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
A leading biotech-focused fund just boosted its Immunome position by a material amount as the stock surged. This arti...
Dive into a clear, education-focused breakdown of the YMM Q1 2026 earnings transcript. Learn how numbers, questions, ...
Box Inc is set to release Q1 results after the bell, with investors watching AI monetization progress and insider sel...
Gaia’s Q1 2026 results reveal how the company is monetizing its growing audience and investing for long-term growth. ...
As Chewy released its latest earnings, investors faced mixed signals: growing revenue and better margins, but cautiou...
AI growth drives data-center electricity demand, creating opportunities for energy players with long-term contracts. ...
When Wells Fargo reports earnings, the spotlight isn’t just on per-share figures. The real story this quarter is net ...
Redwire’s backlog and contract wins are lifting the stock, but the company remains unprofitable. This report weighs t...
Michael Saylor rebutted critics of MicroStrategy's Bitcoin sales as BTC slides and the stock falters. He stressed the...
SpaceX opened at $160.95 per share and briefly topped a $2 trillion valuation on debut, then pulled back to more mode...
AST SpaceMobile and SpaceX surged after the launch of the largest direct-to-phone satellites, signaling a potential s...